サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：薬物乱用治療の世界市場：治療タイプ別（薬物乱用治療、ニコチン中毒治療、アルコール依存症） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1121706

薬物乱用治療の世界市場：治療タイプ別（薬物乱用治療、ニコチン中毒治療、アルコール依存症） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Substance Abuse Treatment Market (Treatment Type: Drug Abuse Treatment, Nicotine Addiction Treatment, and Alcohol Addiction) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 445 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
薬物乱用治療の世界市場：治療タイプ別（薬物乱用治療、ニコチン中毒治療、アルコール依存症） - 業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年07月06日
発行: Transparency Market Research
ページ情報: 英文 445 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の薬物乱用治療市場について調査分析し、市場概要、市場分析、競合情勢、企業プロファイルなどの体系的な情報を提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界の薬物乱用治療市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界の薬物乱用治療市場分析と予測（2017年～2031年）
    • 市場収益予測

第5章 主要な洞察

  • パイプライン分析
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 主要産業の動向
  • 主要企業の製品仕様詳細

第6章 世界の薬物乱用治療市場分析と予測：治療タイプ別

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場金額予測（2017年～2031年）：治療タイプ別
    • アルコール依存症
    • ニコチン中毒
    • 薬物乱用治療
  • 市場魅力分析：治療タイプ別

第7章 世界の薬物乱用治療市場分析と予測：流通チャネルタイプ別

  • イントロダクションと定義
  • 主な調査結果/動向
  • 市場金額予測（2017年～2031年）：流通チャネル別
    • 病院薬局
    • 小売薬局・ドラッグストア
    • その他（ネット販売）
  • 市場魅力分析：流通チャネル別

第8章 世界の薬物乱用治療市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：地域別

第9章 北米の薬物乱用治療市場分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場金額予測（2017年～2031年）：治療タイプ別
    • アルコール依存症
    • ニコチン中毒
    • 薬物乱用治療
  • 市場金額予測（2017年～2031年）：流通チャネル別
    • 病院薬局
    • 小売薬局・ドラッグストア
    • その他（ネット販売）
    • 市場金額予測（2017年～2031年）：流通チャネル別
    • 病院薬局
    • 小売薬局・ドラッグストア
    • その他（ネット販売）
  • 市場金額予測（2017年～2031年）：国別
    • 米国
    • カナダ
  • 市場魅力分析
    • 治療タイプ別
    • 流通チャネル別
    • 国別

第10章 欧州の薬物乱用治療市場分析と予測

第11章 アジア太平洋の薬物乱用治療市場分析と予測

第12章 ラテンアメリカの薬物乱用治療市場分析と予測

第13章 中東・アフリカの薬物乱用治療市場分析と予測

第14章 競合情勢

  • 市場参加企業 - 競合マトリックス（企業ティア・規模別）
  • 市場シェア分析：企業別（2021年）
  • 企業プロファイル
    • Alkermes
    • Allergan plc
    • Indivior plc
    • Noramco (part of SK Capital Partners)
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Mallinckrodt plc
    • BioCorRx, Inc.
    • Glenmark Pharmaceuticals Ltd.
図表

List of Tables

  • Table 1: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
  • Table 2: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment
  • Table 3: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment
  • Table 4: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2017-2031
  • Table 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 6: Global Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 7: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 8: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2017-2031
  • Table 9: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2017-2031
  • Table 10: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2017-2031
  • Table 11: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel
  • Table 12: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 14: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
  • Table 15: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2017-2031
  • Table 16: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2017-2031
  • Table 17: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 18: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 20: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2017-2031
  • Table 21: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2017-2031
  • Table 22: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment
  • Table 23: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel
  • Table 24: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 25: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 26: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2017-2031
  • Table 27: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2017-2031
  • Table 28: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2017-2031
  • Table 29: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 30: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region
  • Table 31: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 32: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2017-2031
  • Table 33: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2017-2031
  • Table 34: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2017-2031
  • Table 35: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 36: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 1: Global Substance Abuse Treatment Market Value (US$ Mn) and Distribution, by Region, 2021 and 2031
  • Figure 2: Global Substance Abuse Treatment Market Value (US$ Mn), by Treatment Type, 2017
  • Figure 3: Global Substance Abuse Treatment Market Value (US$ Mn), by Distribution Channel, 2017
  • Figure 4: Global Substance Abuse Treatment Market Opportunity Map, by Treatment Type, 2022-2031
  • Figure 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 6: Global Substance Abuse Treatment Market Value Share, by Treatment Type, 2021 and 2031
  • Figure 7: Global Substance Abuse Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 8: Global Substance Abuse Treatment Market Value (US$ Mn), by Alcohol Addiction Treatment, 2017-2031
  • Figure 9: Global Substance Abuse Treatment Market Value (US$ Mn), by Nicotine Addiction Treatment, 2017-2031
  • Figure 10: Global Substance Abuse Treatment Market Value (US$ Mn), by Drug Abuse Treatment, 2017-2031
  • Figure 11: Global Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 12: Global Substance Abuse Treatment Market Attractiveness Analysis, by Alcohol Addiction Treatment, 2018-2026
  • Figure 13: Global Substance Abuse Treatment Market Value (US$ Mn), by Acamprosate, 2017-2031
  • Figure 14: Global Substance Abuse Treatment Market Value (US$ Mn), by Disulphirum, 2017-2031
  • Figure 15: Global Substance Abuse Treatment Market Value (US$ Mn), by Naltrexone, 2017-2031
  • Figure 16: Global Substance Abuse Treatment Market Value (US$ Mn), by Benzodiazepine (BZD), 2017-2031
  • Figure 17: Global Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 18: Global Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment, 2022-2031
  • Figure 19: Global Substance Abuse Treatment Market Value (US$ Mn), by Total NRT Therapy, 2017-2031
  • Figure 20: Global Substance Abuse Treatment Market Value (US$ Mn), by Varenicline, 2017-2031
  • Figure 21: Global Substance Abuse Treatment Market Value (US$ Mn), by Bupropion, 2017-2031
  • Figure 22: Global Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 23: Global Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 24: Global Substance Abuse Treatment Market Value (US$ Mn), by Methadone, 2017-2031
  • Figure 25: Global Substance Abuse Treatment Market Value (US$ Mn), by Buprenorphine, 2017-2031
  • Figure 26: Global Substance Abuse Treatment Market Value (US$ Mn), by Naltexone, 2017-2031
  • Figure 27: Global Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 28: Global Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 29: Global Substance Abuse Treatment Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 30: Global Substance Abuse Treatment Market Value (US$ Mn), by Retail Pharmacies & Drug Stores, 2017-2031
  • Figure 31: Global Substance Abuse Treatment Market Value (US$ Mn) by Others (online sales), 2017-2031
  • Figure 32: Global Substance Abuse Treatment Market Attractiveness Analysis, by Region, 2018 and 2026
  • Figure 33: North America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2021 and 2031
  • Figure 34: North America Substance Abuse Treatment Market Value Share, by Treatment, 2017 and 2025
  • Figure 35: North America Substance Abuse Treatment Market Attractiveness Analysis, by Treatment, 2018-2026
  • Figure 36: North America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 37: North America Substance Abuse Treatment Market Attractiveness Analysis, Alcohol Addiction Treatment, 2018-2026
  • Figure 38: North America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 39: North America Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment, 2022-2031
  • Figure 40: North America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 41: North America Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 42: North America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 43: North America Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 44: North America Substance Abuse Treatment Market Value Share, by Country, 2021 and 2031
  • Figure 45: North America Substance Abuse Treatment Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 46: Europe Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2021 and 2031
  • Figure 47: Europe Substance Abuse Treatment Market Value Share, by Treatment, 2017 and 2025
  • Figure 48: Europe Substance Abuse Treatment Market Attractiveness Analysis, by Treatment, 2018-2026
  • Figure 49: Europe Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 50: Europe Substance Abuse Treatment Market Attractiveness Analysis, Alcohol Addiction Treatment, 2018-2026
  • Figure 51: Europe Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 52: Europe Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment, 2022-2031
  • Figure 53: Europe Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 54: Europe Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 55: Europe Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 56: Europe Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 57: Europe Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 58: Europe Substance Abuse Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 59: Asia Pacific Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2021 and 2031
  • Figure 60: Asia Pacific Substance Abuse Treatment Market Value Share, by Treatment, 2017 and 2025
  • Figure 61: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, by Treatment, 2018-2026
  • Figure 62: Asia Pacific Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 63: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, Alcohol Addiction Treatment, 2018-2026
  • Figure 64: Asia Pacific Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 65: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment, 2022-2031
  • Figure 66: Asia Pacific Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 67: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 68: Asia Pacific Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 69: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 70: Asia Pacific Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 71: Asia Pacific Substance Abuse Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 72: Latin America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Treatment, 2021 and 2031
  • Figure 73: Latin America Substance Abuse Treatment Market Value Share, by Treatment, 2017 and 2025
  • Figure 74: Latin America Substance Abuse Treatment Market Attractiveness Analysis, by Treatment, 2018-2026
  • Figure 75: Latin America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 76: Latin America Substance Abuse Treatment Market Attractiveness Analysis, Alcohol Addiction Treatment, 2018-2026
  • Figure 77: Latin America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 78: Latin America Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment, 2022-2031
  • Figure 79: Latin America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 80: Latin America Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 81: Latin America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 82: Latin America Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 83: Latin America Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 84: Latin America Substance Abuse Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 85: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 86: Middle East & Africa Substance Abuse Treatment Market Value Share, by Treatment, 2017 and 2025
  • Figure 87: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 88: Middle East & Africa Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2021 and 2031
  • Figure 89: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Alcohol Addiction Treatment, 2022-2031
  • Figure 90: Middle East & Africa Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2021 and 2031
  • Figure 91: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Nicotine Addiction Treatment,
  • Figure 92: Middle East & Africa Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2021 and 2031
  • Figure 93: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Drug Abuse Treatment, 2022-2031
  • Figure 94: Middle East & Africa Substance Abuse Treatment Market Value Share, by Distribution Channel, 2021 and 2031
  • Figure 95: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 96: Middle East & Africa Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2021 and 2031
  • Figure 97: Middle East & Africa Substance Abuse Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
目次
Product Code: TMRGL4067

The report provides revenue of the global substance abuse treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global substance abuse treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the substance abuse treatment market.

The report delves into the competitive landscape of the global substance abuse treatment market. Key players operating in the global substance abuse treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global substance abuse treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Substance Abuse Treatment Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Substance Abuse Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Porter's Five Force Analysis
  • 5.3. Value Chain Analysis
  • 5.4. Key Industry Development
  • 5.5. Top Company's Product Specification Details

6. Global Substance Abuse Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2017-2031
    • 6.3.1. Alcohol Addiction
      • 6.3.1.1. Disulfiram
      • 6.3.1.2. Acamprosate
      • 6.3.1.3. Naltrexone
      • 6.3.1.4. Others
    • 6.3.2. Nicotine Addiction
      • 6.3.2.1. Total NRT Therapy
      • 6.3.2.2. Varenicline
      • 6.3.2.3. Bupropion
    • 6.3.3. Drug Abuse Treatment
      • 6.3.3.1. Methadone
      • 6.3.3.2. Buprenorphine
      • 6.3.3.3. Naltexone
  • 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Substance Abuse Treatment Market Analysis and Forecast, by Distribution Channel Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies & Drug Stores
    • 7.3.3. Others (online sales)
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Substance Abuse Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Substance Abuse Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 9.2.1. Alcohol Addiction
      • 9.2.1.1. Disulfiram
      • 9.2.1.2. Acamprosate
      • 9.2.1.3. Naltrexone
      • 9.2.1.4. Others
    • 9.2.2. Nicotine Addiction
      • 9.2.2.1. Total NRT Therapy
      • 9.2.2.2. Varenicline
      • 9.2.2.3. Bupropion
    • 9.2.3. Drug Abuse Treatment
      • 9.2.3.1. Methadone
      • 9.2.3.2. Buprenorphine
      • 9.2.3.3. Naltexone
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies & Drug Stores
    • 9.3.3. Others (online sales)
    • 9.3.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.5. Hospital Pharmacies
    • 9.3.6. Retail Pharmacies & Drug Stores
    • 9.3.7. Others (online sales)
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Treatment Type
    • 9.5.2. By Distribution Channel Type
    • 9.5.3. By Country

10. Europe Substance Abuse Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 10.2.1. Alcohol Addiction
      • 10.2.1.1. Disulfiram
      • 10.2.1.2. Acamprosate
      • 10.2.1.3. Naltrexone
      • 10.2.1.4. Others
    • 10.2.2. Nicotine Addiction
      • 10.2.2.1. Total NRT Therapy
      • 10.2.2.2. Varenicline
      • 10.2.2.3. Bupropion
    • 10.2.3. Drug Abuse Treatment
      • 10.2.3.1. Methadone
      • 10.2.3.2. Buprenorphine
      • 10.2.3.3. Naltexone
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies & Drug Stores
    • 10.3.3. Others (online sales)
    • 10.3.4. Market Value Forecast, by Distribution Channel, 2017-2031
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Treatment Type
    • 10.5.2. By Distribution Channel Type
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Substance Abuse Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 11.2.1. Alcohol Addiction
      • 11.2.1.1. Disulfiram
      • 11.2.1.2. Acamprosate
      • 11.2.1.3. Naltrexone
      • 11.2.1.4. Others
    • 11.2.2. Nicotine Addiction
      • 11.2.2.1. Total NRT Therapy
      • 11.2.2.2. Varenicline
      • 11.2.2.3. Bupropion
    • 11.2.3. Drug Abuse Treatment
      • 11.2.3.1. Methadone
      • 11.2.3.2. Buprenorphine
      • 11.2.3.3. Naltexone
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies & Drug Stores
    • 11.3.3. Others (online sales)
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of APAC
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Treatment Type
    • 11.5.2. By Distribution Channel Type
    • 11.5.3. By Country/Sub-region

12. Latin America Substance Abuse Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 12.2.1. Alcohol Addiction
      • 12.2.1.1. Disulfiram
      • 12.2.1.2. Acamprosate
      • 12.2.1.3. Naltrexone
      • 12.2.1.4. Others
    • 12.2.2. Nicotine Addiction
      • 12.2.2.1. Total NRT Therapy
      • 12.2.2.2. Varenicline
      • 12.2.2.3. Bupropion
    • 12.2.3. Drug Abuse Treatment
      • 12.2.3.1. Methadone
      • 12.2.3.2. Buprenorphine
      • 12.2.3.3. Naltexone
  • 12.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies & Drug Stores
    • 12.3.3. Others (online sales)
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of LATAM
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Treatment Type
    • 12.5.2. By Distribution Channel Type
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Substance Abuse Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2017-2031
    • 13.2.1. Alcohol Addiction
      • 13.2.1.1. Disulfiram
      • 13.2.1.2. Acamprosate
      • 13.2.1.3. Naltrexone
      • 13.2.1.4. Others
    • 13.2.2. Nicotine Addiction
      • 13.2.2.1. Total NRT Therapy
      • 13.2.2.2. Varenicline
      • 13.2.2.3. Bupropion
    • 13.2.3. Drug Abuse Treatment
      • 13.2.3.1. Methadone
      • 13.2.3.2. Buprenorphine
      • 13.2.3.3. Naltexone
  • 13.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies & Drug Stores
    • 13.3.3. Others (online sales)
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of MEA
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Treatment Type
    • 13.5.2. By Distribution Channel Type
    • 13.5.3. By Country/Sub-region

14. Competitive Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Alkermes
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Company Financials
      • 14.3.1.3. Growth Strategies
      • 14.3.1.4. SWOT Analysis
    • 14.3.2. Allergan plc
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Company Financials
      • 14.3.2.3. Growth Strategies
      • 14.3.2.4. SWOT Analysis
    • 14.3.3. Indivior plc
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Company Financials
      • 14.3.3.3. Growth Strategies
      • 14.3.3.4. SWOT Analysis
    • 14.3.4. Noramco (part of SK Capital Partners)
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Company Financials
      • 14.3.4.3. Growth Strategies
      • 14.3.4.4. SWOT Analysis
    • 14.3.5. Teva Pharmaceutical Industries Ltd.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Company Financials
      • 14.3.5.3. Growth Strategies
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. Pfizer, Inc.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Company Financials
      • 14.3.6.3. Growth Strategies
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. GlaxoSmithKline plc
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Company Financials
      • 14.3.7.3. Growth Strategies
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. Mallinckrodt plc
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Company Financials
      • 14.3.8.3. Growth Strategies
      • 14.3.8.4. SWOT Analysis
    • 14.3.9. BioCorRx, Inc.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Company Financials
      • 14.3.9.3. Growth Strategies
      • 14.3.9.4. SWOT Analysis
    • 14.3.10. Glenmark Pharmaceuticals Ltd.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Company Financials
      • 14.3.10.3. Growth Strategies
      • 14.3.10.4. SWOT Analysis